Loading clinical trials...

Enrolling By InvitationNCT07163260

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the e...

Lead sponsor: Novo Nordisk A/S•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814 · Haemophilia A (Moderate or Severe)

RECRUITING

The CACHE Study: Coronary Artery Care in HaEmophilia

NCT06706206 · Haemophilia, Cardiovascular Diseases

RECRUITING

Prevalence of Synovitis in Patients With Haemophilia A

NCT06352216 · Haemophilia A, Synovitis, and more

Enrolling By Invitation

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

NCT06285071 · Haemophilia A, Haemophilia B

Enrolling By Invitation

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734 · Haemophilia A, Haemophilia B

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 24, 2025Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

Phase—

Enrollment244

Start dateJan 2025

Last updatedOct 24, 2025

Condition

Haemophilia

Locations shown

Novo Nordisk Investigational Site

Bangalore, Karnataka

Novo Nordisk Investigational Site

Kuala Lumpur

Novo Nordisk Investigational Site

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 24, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

The CACHE Study: Coronary Artery Care in HaEmophilia

Prevalence of Synovitis in Patients With Haemophilia A

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Trial snapshot

Condition

Locations shown

For caregivers